November Spotlight: Breakthrough in Cancer Treatment Monitoring
DELFI-TF is a groundbreaking, non-invasive cancer diagnostic method using cell-free DNA. Highlighting its tech transfer potential, scalability, and broad clinical applications, this study bridges cutting-edge research and real-world oncology solutions.